$101.13
0.120.12%
In chiusura: Nov 25, 4:00 PM EST
$100.95
-0.18-0.18%
After hour: 5:24 PM EST
Comments
Loading...
Stime degli utili, EPS e fatturato
Exact Sciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
feb 18
Stima EPS
$0.080
Stima dei ricavi trimestrali
$860.68M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$3.08B
Analizza lo storico degli utili di Exact Sciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
EXAS | Exact Sciences | -$0.06 | $0.08 | — | — | $713.42M | $860.68M | — | — | 02/18/2026 | |
EXAS | Exact Sciences | $0.07 | $0.15 | $0.24 | 60.00% | $708.65M | $810.51M | $850.74M | 4.96% | 11/03/2025 | |
EXAS | Exact Sciences | -$0.09 | $0.02 | -$0.01 | -150.00% | $699.26M | $774.43M | $811.09M | 4.73% | 08/06/2025 | |
EXAS | Exact Sciences | -$0.60 | -$0.37 | -$0.21 | 43.24% | $637.52M | $689.35M | $706.78M | 2.53% | 05/01/2025 | |
EXAS | Exact Sciences | -$0.27 | -$0.31 | -$0.06 | 80.65% | $646.88M | $701.30M | $713.42M | 1.73% | 02/19/2025 | |
EXAS | Exact Sciences | $0.00 | -$0.21 | -$0.21 | 0.00% | $628.34M | $717.66M | $708.65M | -1.25% | 11/05/2024 | |
EXAS | Exact Sciences | -$0.45 | -$0.32 | -$0.09 | 71.88% | $622.09M | $690.00M | $699.26M | 1.34% | 07/31/2024 | |
EXAS | Exact Sciences | -$0.42 | -$0.46 | -$0.60 | -30.43% | $602.45M | $627.17M | $637.52M | 1.65% | 05/08/2024 | |
EXAS | Exact Sciences | -$0.72 | -$0.46 | -$0.27 | 41.30% | $553.00M | $637.22M | $646.88M | 1.52% | 02/21/2024 | |
EXAS | Exact Sciences | -$0.84 | -$0.48 | $0.00 | 100.00% | $523.07M | $616.81M | $628.34M | 1.87% | 11/01/2023 | |
EXAS | Exact Sciences | -$0.90 | -$0.50 | -$0.45 | 10.00% | $521.64M | $599.03M | $622.09M | 3.85% | 08/01/2023 | |
EXAS | Exact Sciences | -$1.04 | -$0.75 | -$0.42 | 44.00% | $486.57M | $543.46M | $602.45M | 10.85% | 05/09/2023 | |
EXAS | Exact Sciences | -$1.28 | -$0.84 | -$0.72 | 14.29% | $473.81M | $528.22M | $553.00M | 4.69% | 02/21/2023 | |
EXAS | Exact Sciences | -$0.79 | -$1.08 | -$0.84 | 22.22% | $456.38M | $502.94M | $523.07M | 4.00% | 11/03/2022 | |
EXAS | Exact Sciences | -$1.03 | -$1.07 | -$0.90 | 15.89% | $434.82M | $497.50M | $521.64M | 4.85% | 08/02/2022 | |
EXAS | Exact Sciences | -$0.18 | -$1.07 | -$1.04 | 2.80% | $402.08M | $461.71M | $486.57M | 5.38% | 04/26/2022 | |
EXAS | Exact Sciences | -$0.15 | -$1.04 | -$1.28 | -23.08% | $466.34M | $449.00M | $473.81M | 5.53% | 02/22/2022 | |
EXAS | Exact Sciences | -$0.07 | -$0.85 | -$0.79 | 7.06% | $408.36M | $430.03M | $456.38M | 6.13% | 11/02/2021 | |
EXAS | Exact Sciences | -$0.58 | -$0.76 | -$1.03 | -35.53% | $268.87M | $421.28M | $434.82M | 3.21% | 07/28/2021 | |
EXAS | Exact Sciences | -$0.66 | -$1.03 | -$0.18 | 82.52% | $347.82M | $388.57M | $402.08M | 3.48% | 05/04/2021 | |
EXAS | Exact Sciences | -$0.37 | -$0.22 | -$0.15 | 31.82% | $295.57M | $446.22M | $466.34M | 4.51% | 02/16/2021 |
Exact Sciences (EXAS) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $0.24 | $0.15 | 60.0 % |
| Q2 | 2025-08-06 | $-0.01 | $0.02 | -150.0 % |
| Q1 | 2025-05-01 | $-0.21 | $-0.37 | 43.2 % |
| Q4 | 2025-02-19 | $-0.06 | $-0.31 | 80.7 % |
Exact Sciences (EXAS) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $850.74M | $810.51M | 4.96 % |
| Q2 | 2025-08-06 | $811.09M | $774.43M | 4.73 % |
| Q1 | 2025-05-01 | $706.79M | $689.35M | 2.53 % |
| Q4 | 2025-02-19 | $713.42M | $701.30M | 1.73 % |
FAQ
Quando Exact Sciences (NASDAQ:EXAS) riporterà gli utili?
Si prevede che Exact Sciences (EXAS) fornisca risultati il febbraio 18, 2026. Gli ultimi risultati sono stati pubblicati il novembre 3, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Exact Sciences (NASDAQ:EXAS)?
L'EPS effettivo era $0.24, che superato la stima di $0.15.
Quali sono state le entrate di Exact Sciences (NASDAQ:EXAS)?
Le entrate effettive sono state $850.7M, che superato la stima di $810.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.